Promising long-term vaccine for Crimean-Congo hemorrhagic fever developed
Crimean-Congo hemorrhagic fever (CCHF) is one of the world’s most dangerous yet overlooked infectious diseases. Spread by ticks…
NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus
Crimean-Congo hemorrhagic fever virus, or CCHFV, is a biosafety level 4 pathogen and a Category A bioterrorism agent,…